Aknamed acquired by PharmEasy at $144 Mn valuation; co-founders exit

  • IPO-bound online pharmacy company PharmEasy has acquired a controlling stake in Bengaluru-based healthcare supply chain startup Aknamed in a primary and secondary deal.
  • Importantly, PharmEasy has completely bought out the stake of five promoters of Aknamed who collectively controlled a 50.67% stake.
  • According to Fintrackr’s estimates, investment by PharmEasy in Aknamed has been concluded at an enterprise valuation of Rs 1,060 crore or $144 million.


Leave a Reply

Your email address will not be published. Required fields are marked *